Jim Oates to Immunosuppressive Agents
This is a "connection" page, showing publications Jim Oates has written about Immunosuppressive Agents.
Connection Strength
0.246
-
Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2022 01; 74(1):112-123.
Score: 0.148
-
At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases. J Leukoc Biol. 2016 Feb; 99(2):265-78.
Score: 0.098